✦ LIBER ✦

TGN1412 and The Lancet's solicitation of reports of phase I trials

✍ Scribed by Iain Chalmers

Book ID: 117300389
Publisher: The Lancet
Year: 2006
Tongue: English
Weight: 50 KB
Volume: 368
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(06)69885-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytokine Storm in a Phase 1 Trial of the

Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

✍ Suntharalingam, Ganesh; Perry, Meghan R.; Ward, Stephen; Brett, Stephen J.; Cast 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 402 KB

Money and Distorted Ethical Judgments ab

Money and Distorted Ethical Judgments about Research: Ethical Assessment of the TeGenero TGN1412 Trial

✍ Emanuel, Ezekiel J.; Miller, Franklin G. 📂 Article 📅 2007 🏛 Taylor and Francis Group 🌐 English ⚖ 86 KB

Some aspects of the recombinantly expres

Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials

✍ Jitendra N. Mehrishi; Miklós Szabó; Tibor Bakács 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 837 KB

Pediatric Phase I Trial and Pharmacokine

Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium

✍ Aplenc, R.; Blaney, S. M.; Strauss, L. C.; Balis, F. M.; Shusterman, S.; Ingle, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 180 KB

14A Publication and reporting of phase I

14A Publication and reporting of phase I clinical trials

✍ Marcy Winget 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Initial report of the phase I trial of t

Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508

✍ C.Norman Coleman; Raul C. Urtasun; Todd H. Wasserman; Steven Hancock; John W. Ha 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 573 KB